Emerging Markets, PTV News: May 14, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Emerging Markets, PTV News: May 14, 2010
Released on: May 14, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
Abbott speeds-up its pharmaceutical leadership in emerging markets with a Zydus Cadila collaboration
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Jansen Jacob
Analyst
PharmaVentures

Jansen’s expertise lies in transactions, business strategy & planning as well as market and competitor analysis. His skills include product and technology valuations, benchmarking, deal structuring and litigation support in the pharmaceutical sector. With over 15 years in the life science sector Jansen’s experience covers DNA therapeutics, immunotherapy, animal health and plant science research. Jansen holds a chemistry degree from Gandhiji University, a DPhil in Biochemistry from the University of Sussex and an MBA from Oxford Brookes University.
Zydus Cadila
Zydus Cadila is an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products. The group’s operations range from API to formulations, animal health products and cosmeceuticals.
Abbott Laboratories
Abbott Laboratories is a diversified pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois.

Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2008, Abbott had over $29 billion in revenue.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK